Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola
October 20, 2014 at 12:01 PM EDT
Hemispherx Biopharma, Inc. (NYSE MKT: HEB) (the "Company" or "Hemispherx"), has retained Squire Patton Boggs (SPB) to serve as its ...
